XBiotech Inc. (XBIT) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Austin, TX, United States. The current CEO is Sushma Shivaswamy.
XBIT has IPO date of 2015-04-15, 92 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $75M.
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
